|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2003-11-25
|
|
pubmed:abstractText |
The aim of this study was to determine the efficacy of epoetin alfa in alleviating anemia and minimizing ribavirin (RBV) dose reductions in patients with chronic hepatitis C virus (HCV) infection receiving combination RBV/interferon alfa (IFN) therapy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0002-9270
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
98
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2491-9
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:14638354-Adolescent,
pubmed-meshheading:14638354-Adult,
pubmed-meshheading:14638354-Aged,
pubmed-meshheading:14638354-Analysis of Variance,
pubmed-meshheading:14638354-Anemia,
pubmed-meshheading:14638354-Dose-Response Relationship, Drug,
pubmed-meshheading:14638354-Drug Administration Schedule,
pubmed-meshheading:14638354-Drug Synergism,
pubmed-meshheading:14638354-Drug Therapy, Combination,
pubmed-meshheading:14638354-Erythropoietin,
pubmed-meshheading:14638354-Female,
pubmed-meshheading:14638354-Follow-Up Studies,
pubmed-meshheading:14638354-Hepacivirus,
pubmed-meshheading:14638354-Hepatitis C, Chronic,
pubmed-meshheading:14638354-Humans,
pubmed-meshheading:14638354-Interferon-alpha,
pubmed-meshheading:14638354-Male,
pubmed-meshheading:14638354-Middle Aged,
pubmed-meshheading:14638354-Probability,
pubmed-meshheading:14638354-Recombinant Proteins,
pubmed-meshheading:14638354-Reference Values,
pubmed-meshheading:14638354-Ribavirin,
pubmed-meshheading:14638354-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus-infected patients receiving ribavirin plus interferon alfa.
|
|
pubmed:affiliation |
Mount Sinai School of Medicine, New York, New York 10029-6574, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
